Jiangsu Jibeier Pharmaceutical Investor Relations Material
Latest events
Q4 2024
15 Apr, 2025
Q3 2024
26 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Jiangsu Jibeier Pharmaceutical
Access all reports
Jiangsu Jibeier Pharmaceutical Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and sale of pharmaceutical products. The company specializes in treatments for chronic and infectious diseases, providing a portfolio of products that includes antibiotics, antiviral drugs, and health supplements. The company is headquartered in Suzhou, China, and its shares are listed on the Shanghai Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
688566
Country
🇨🇳 China